We’re excited to announce that Digistain® has partnered Deloitte to drive adoption across Europe!
This collaboration marks a significant step toward making breast cancer risk profiling faster, more affordable, and accessible to more patients than ever before.
Together, we’re working to transform cancer care for the better.
Last week, we were proud to present two abstracts at the San Antonio Breast Cancer Symposium 2024. The first abstract showcased head-to-head data from Charing
We’re excited to announce that Digistain® has partnered Deloitte to drive adoption across Europe! This collaboration marks a significant step toward making breast cancer risk
We’re thrilled to announce that Digistain® is now available to over 60% of UK private patients, with reimbursement available though Bupa, WPA Health Insurance &
Supported by:
To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.
Digistain LIMITED, Unit 101, Interchange Business Park, Howard Way, Newport Pagnell, MK16 9PY, United Kingdom
From the UK: 020 3951 9812
Outside the UK: +44 20 3951 9812
e-mail: contact@digistain.co.uk
Copyright © 2010 - 2025. Digistain ® and the Digistain Logo are registered trademarks of Digistain LIMITED. All Rights Reserved.
